Orchid Cellmark Trims Loss as Revenues Rise 15 Percent in Q2 | GenomeWeb
NEW YORK (GenomeWeb News) — Orchid Cellmark yesterday said second-quarter revenue rose 15 percent, R&D spending fell 9 percent, and it slashed its net loss more than five-fold.
Total receipts for the three months ended June 30 increased to $15.7 million from $13.6 million year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.